BarryAlanSiegelMD

Nuclear Medicine • Saint Louis, MO

Professor of Radiology, Washington University St Louis

Join to view full profile

Dr. Siegel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Siegel's full profile

Already have an account?

Office
510 S Kingshighway Blvd
Dept
Saint Louis, MO 63110
Phone+1 314-362-7200

Fax+1 314-747-4189

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Radiology-Diagnostic, 1970 - 1973
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1969 - 1970
Washington University in St. Louis School of MedicineClass of 1969

Certifications & Licensure

MO State Medical License 1969 - 2025
American Board of Nuclear Medicine Nuclear Medicine
American Board of Radiology Diagnostic Radiology
American Board of Radiology Nuclear Radiology

Awards, Honors, & Recognition

Gold Medal American College of Radiology, 2021
Benedict Cassen Prize Society of Nuclear Medicine and Molecular Imaging, 2014
Georg Charles de Hevesy Nuclear Pioneer Award for Outstanding Contributions to Nuclear Medicine Society of Nuclear Medicine, 2003
America's Top Doctors Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
St. Louis Magazine: Top Doctors Castle Connolly, 2001
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy Start of enrollment: 2007 Mar 30
Terminated
Not Applicable
Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma Start of enrollment: 2009 Mar 01
Completed
Phase 2
The National Oncologic PET Registry Start of enrollment: 2006 May 01
Active, not recruiting
MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2009 Aug 24
Completed
Phase 2
GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer Start of enrollment: 2013 Feb 01
Completed
Phase 2
Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC) Start of enrollment: 2013 May 31
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

37 citations
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidenc...
Consuelo H Wilkins, Charles C Windon, Peggye Dilworth-Anderson, Justin Romanoff, Constantine Gatsonis
JAMA Neurology. 2022-10-03
178 citations
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).
Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe, Peter R. Carroll, Frédéric Pouliot
The Journal of Urology. 2021-02-26
47 citations
Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
Stephanie Markovina, Songyan Wang, Lauren E. Henke, Cliff J. Luke, Stephen C. Pak
British Journal of Cancer. 2018-01-01

Press Mentions

Siteman Cancer Center Awarded $7.8 Million to Expand Clinical Trials AccessAugust 1st, 2019
Dehdashti Named Siegel Professor of RadiologyJuly 25th, 2019
[Results of Lung Cancer Screening Among Urban Residents in Kunming]July 2nd, 2019
Join now to see all

Grant Support

Image Response Assessment TEAMNational Cancer Institute2010–2011
Core--Protocol Review And MonitoringNational Cancer Institute2001–2002